SNY talks for 121 and 398 is dead until we have 305 bodies. They will update nothing. Not gonna happen.
Find a good book to read. Next news will be a major collaboration. When? It's Mulroy at the controls. He has less credibility than Obama.
There was a .10 bid for the Feb!!!!! $2.50 calls..You buy the stock and sell the call and it is a 36% return for 19 days....Annual that puppy
You are preaching to the choir..This company has no message. As I said, MIT, Harvard, Cambridge mafia that gives itself tons of options and could care less about the shareholder. Mulroy promised deals for the last two years and we got zip. With all the drug companies running out of patent protection and having nothing in the clinic you would think our dopey management would do something. I bet you can't wait for the next financing...
This has nothing to do with ETRM...The market will buy the stock when they get the FDA meeting and big institutions will buy when it gets approved. Outside of T Rowe and a few others it is very hard to buy a stock at $2.00. You can't margin this stock so the cash specks have to sell when someone utters the words:
" Margin call gentlemen."
I am bidding for calls and they are wildy overpriced and no one wants to sell them.
Off hand I would guess hedge fund selling..MACK did not participate in the biotech run so they bail..
No news..but the company's PR machine went over a cliff...
I agree with a lot of what you say, but this is a Cambridge, Harvard, MIT cabal and they would never seek VC money. Look at the biggest owner.Fidelity..and as usual they say nothing and that is the Boston mentality. The board has not business people on it. That woman from JP Morgan is from their asset management group. Patently useless. Sorry to say we are going to have to suffer Mulroy et al until they produce. Even then we may not reach our potential because entrenched management will still be there. I think the CFO is quite clueless also, but that is for another discussion. Mulroy is a nice fellow but should not be running a company.
My biggest fear, Mulroy and the Board own a ton of stock and may feel like cashing out sooner than they should.
Thanks..Interesting post...We need some large institutions to hear Robert speak. No matter what the EPA says, coal is not going away as a U.S. power source. We are not building any more nuclear and sun and wind are still ludicrous. What staggers me, a small sardine in the American River in California as stopping water from going into the Central Valley.
Save a MF fish and starve the state of water. Coal. SYMX has some of it figured out.They will work on the rest. This is my favorite investment. Like that idiot Ichan says of Apple, " a no brainer."
You have no idea how good it is going to get. A friend spoke to the company and they are very optimistic and are seeing a great number of new inquiries. Still, the first GE deal to build somewhere will be a watershed event. My feeling is making 5.9MM for 2 months in 2013 augers well that they will not need to finance down here. From the CC I get a feeling the YIMA problem is wearing thin on them but it is a government deal. The retrofits et al are still in the process. Now if that Wisconsin PR firm does some work we may find a few new investors. The Chairman's brother must run the place.
May I comment here. Let us talk simple valuation. Last week an RNAi based company went public. It was called Dicerna. I have know about them for 10 years and have great respect for the John Rossi, one of the company founders and one of the original RNAi investigators. But they have nothing in any clinic. But they have a market cap of 1.15 Billion out of the gate! Sure, new issue, sexy science ( that to me is years away not withstanding Sanofi's recent $700 M reach onto industry leader Alnylam ) but look at where MACK sits, what we have and who owns us and our pathetic market cap.
Echoing Boogin's comments, Bob Mulroy assembled a great team. However, he is like a great general manager of a pro sports franchise. He has no idea how to coach a team! He is useless in press conferences because he does not understand his audience. Further,
MACK probably has the worst Board of Directors on the planet. They can't get financing right even though they has a J P Morgan heavy ( in her own mind ) on the board.
You want to talk about value. Mulroy ( I will start calling him Theo Epstein ) has done a good job assembling assets of people and business. I thought the deal with Cancer Centers of America was smart as was getting 398 at the other compounds for almost nothing. But quoting an old pal, " Bob Mulroy could not get laid in a women's prison with a handful of pardons " when it comes to running this company . Our share price is an image of Bob's failure to communicate our presence. I could mention ten other companies that have 1/5 of our potential that trade miles above us.
I don't want to beat a dead horse. If you don't communicate with the right audience you get the garbage the analysts spew. It also opens us up to give this company away for nothing to a potential suitor. That scares me the most.
The delay in 398 is patient survival. If there was a change in the trial for any reason that is considered a material event and would have to be disclosed. Remember 20% of the Phase II patients lived 2 years ( 8 patients ). I think their hiring plans could be considered a sign of confidence, but the biotech industry is littered with hopes that get dashed, but I think we are fine with 398. The market does not think so as our market cap is ridiculous.
That is very gentlemanly of you. You asked about a standstill. Controlling? What are you a psychiatrist?
Let me try to give you my thoughts. A standstill is useless if you have a meaningless company. SNY can't buy any shares until 4/1. They also have to pay a milestone. I would imagine they are dragging their feet, as they do own 5% of MACK. It does not hurt them to wait until 398 gets exposed to make a decision on whether the milestone would be better spent buying the company.
By the way, MACK should be trading with a 1.5 billion market cap right now. If you look at the competition in our space we should all be a little frustrated with management. I am and do not think they are very investor friendly. But I guess you knew that, being such a thorough investigator.
By the way, I should have expected your response as you have to be an Indians fan!
Useless...I have never ben called that...
Well you explain it. You seem to know everything there is to know about anything. When someone asks a question that I consider useless I will at least point him in the right direction. They guy does not even know what stock is buying. Give it a rest will you.